Toward Single-Time-Point Image-Based Dosimetry of (177)Lu-PSMA-617 Therapy

Radiopharmaceutical therapies (RPTs) with (177)Lu-prostate-specific membrane antigen (PSMA) ligands have demonstrated promising results for the treatment of metastatic castration-resistant prostate cancer. The lack of absorbed-dose–effect relationships currently prevents patient-specific activity pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Brosch-Lenz, Julia, Delker, Astrid, Völter, Friederike, Unterrainer, Lena M., Kaiser, Lena, Bartenstein, Peter, Ziegler, Sibylle, Rahmim, Arman, Uribe, Carlos, Böning, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2023
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152120/
https://www.ncbi.nlm.nih.gov/pubmed/36657980
http://dx.doi.org/10.2967/jnumed.122.264594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152120/
https://www.ncbi.nlm.nih.gov/pubmed/36657980
http://dx.doi.org/10.2967/jnumed.122.264594

Ejemplares similares